Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + docetaxel in metastatic breast cancer
NCT00774241Phase 4Withdrawn
- Sponsor
- Roche
- Start
- Jan 2010
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of bevacizumab in breast cancer, sponsored by Roche. Planned start Jan 2010; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00774241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774241.